About
Aaron Edwards is CEO and Co-Founder of KiraGen Bio, a company developing gene-edited CAR-T therapies for solid tumors that combines AI with biological research to select and validate multiplex gene edits, beginning with glioblastoma. He has over a decade of experience in gene editing, cell therapy, immunotherapy, mRNA therapeutics, and vaccine design, including prior roles at Beam Therapeutics and bluebird bio, and serves on the Scientific Advisory Board of RNAlead. Edwards holds an MS/MBA in Biotechnology: Life Sciences from Harvard Business School and the Graduate School of Arts and Sciences, and is a Termeer Fellow and Blavatnik Fellow.
Founder at KiraGen Bio
Intro paths
→
In turn, Aaron can intro founders to KiraGen Bio's investors below.
KiraGen Bio's investors · 3
Co-founders at KiraGen Bio
RM
Ryan Murray, PhDFounder
Experience
- RNAleadScientific Advisory Board Membercurrent2025 — present
- Centre CollegeAlumni Board Membercurrent2024 — presentDanville, Kentucky, United States
- KiraGen BioCo-Founder/CEOcurrent2023 — presentBoston, Massachusetts, United States
- Harvard Business SchoolBlavatnik Foundation Life Science Entrepreneurship Fellow2024 — 2025Cambridge, Massachusetts, United States
- The Termeer FoundationHenri Termeer Foundation Fellow2024 — 2025Boston, Massachusetts, United States
- Blavatnik Biomedical Accelerator at Harvard UniversityBlavatnik Biomedical Accelerator-Nucleate Venture Creation Intern2023 — 2024
- Eli Lilly and CompanyGenetic Medicine- External Partnership & Academic Collaborations-Intern2023Cambridge, Massachusetts, United States
- Rejuvenate BioBusiness Development Intern2023
- NucleateNational Director of Justice, Diversity, Equity & Inclusion (JDEI)2022 — 2023Boston, Massachusetts, United States
- 1910 GeneticsBusiness Development Intern2022Boston, Massachusetts, United States
- BioMarin Pharmaceutical Inc.Business Development Intern2022San Rafael, California, United States
- DeciBioCell Therapy Analyst2022Boston, Massachusetts, United States
- Beam TherapeuticsScientist, BEAM-201 In Vitro Biology Lead2020 — 2022Cambridge, Massachusetts, United States
- Beam TherapeuticsPrincipal Research Associate, BEAM-201 In Vitro Biology Lead2019 — 2020Cambridge, Massachussetts
- Beam TherapeuticsSenior Research Associate II2018 — 2019Cambridge, Massachusetts
- bluebird bioSenior Associate Scientist I2017 — 2018Cambridge, Massachusetts
- bluebird bioAssociate Scientist II2015 — 2017Cambridge, Massachusetts
- Novartis VaccinesScientific Associate II/Assistant Lab Manager2014 — 2015Cambridge, Massachusetts
- Ragon Institute of MGH, MIT and HarvardGraduate Research Assistant/Technician II2013 — 2014
- Vanderbilt UniversityNational Science Foundation REU Intern2010Department of Chemistry
- Moffitt Cancer CenterResearch Intern2009Department of Molecular Oncology
- Moffitt Cancer CenterAmerican Cancer Society Research Intern2008Department of Molecular Oncology
- Western Kentucky UniversityResearch Assistant2007 — 2008Department of Biology
Skills & more
Electroporation11Gene editing8Western Blotting20ELISA16Immunology19Molecular Cloning17Cell Culture19Gene Therapy6Primary Cell Isolation2TCR1Monoclonal Antibodies5Cell-based assays2
+12 more
RNA isolationAssay DevelopmentFlow CytometryTransfectionGel ElectrophoresisqRT-PCRProtein PurificationqPCRRNA SynthesismRNA nucleotide modificationsmRNA TherapeuticsCAR-TLanguages English
From Aaron's professional profile.
Frequently asked questions
- Who is Aaron Edwards?
- Aaron Edwards is CEO and Co-Founder of KiraGen Bio, a company developing gene-edited CAR-T therapies for solid tumors that combines AI with biological research to select and validate multiplex gene edits, beginning with glioblastoma. He has over a decade of experience in gene editing, cell therapy, immunotherapy, mRNA therapeutics, and vaccine design, including prior roles at Beam Therapeutics and bluebird bio, and serves on the Scientific Advisory Board of RNAlead. Edwards holds an MS/MBA in Biotechnology: Life Sciences from Harvard Business School and the Graduate School of Arts and Sciences, and is a Termeer Fellow and Blavatnik Fellow.
- Where does Aaron Edwards work?
- Aaron Edwards is Founder of KiraGen Bio.
- What companies did Aaron Edwards found?
- Aaron Edwards founded KiraGen Bio.
- Where did Aaron Edwards go to school?
- Aaron Edwards studied at Harvard Business School (MS/MBA Biotechnology: Life Sciences, Biotechnology and Business); Harvard Kenneth C. Griffin Graduate School of Arts and Sciences (MS/MBA Biotechnology: Life Sciences); Boston University School of Medicine (Master of Science (MSc), Medical Sciences (Immunology/Virology)).
Founder mafias
Harvard Business School mafia538
Also came through, then founded or led a company.
Mike Maples JrMBAFounded Pattern BreakersHristo BorisovOPM Class 64Founded PayhawkNoubar AfeyanVisiting LecturerFounded ProFound Therapeutics +12Wade MyersMBAFounded RealManage +6Ellen RubinMBAFounded ClearSky Data +2Spencer RascoffVisiting Executive ProfessorFounded HeyLibby +2
+ 531 more
Harvard Kenneth C. Griffin Graduate School of Arts and Sciences mafia7
Also came through, then founded or led a company.
Adar ArnonMaster of Science - MSFounded SafeBaseJorge GuerraDoctor of Philosophy - PhDFounded LotasWilliam NickolsMaster of ArtsFounded LotasJay ChooiMaster of Arts - MAFounded RobocurveArmon BättigProfessional Certificate ProgramFounded LedgyAlina SuFormer PhD Candidate (On Leave)Founded Generation Lab
Bluebird Bio mafia4
Also came through, then founded or led a company.
Boston University School of Medicine mafia4
Also came through, then founded or led a company.
Beam Therapeutics mafia3
Also came through, then founded or led a company.
Same school
Also attended Harvard Business School2,000
Brad GerstnerFounder & CEO of Altimeter CapitalTim DraperFounder of Draper AssociatesMamoon HamidPartner at Kleiner PerkinsNeeraj AgrawalGeneral Partner at Battery VenturesVictoria TreygerGeneral Partner at Felicis VenturesDeep NisharInvestment Team at General Catalyst
+ 1,994 more
Also attended Harvard Kenneth C. Griffin Graduate School of Arts and Sciences14
Danny CrichtonPartner, Research at Lux Capital, publishing the Securities newsletter and RiskgamingDavid BorcsokPartner at Mucker CapitalConnie LiPrincipal at F-Prime Capital PartnersRyan PeerAssociate at Frazier Life SciencesErik KnallInvestment Associate at Prime Impact FundAnn LaiGeneral Partner at Bullpen Capital
+ 8 more
Also attended Boston University School of Medicine9
Parth DesaiPartner at Flare Capital PartnersBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalMonica JainVenture Partner at Wavemaker Three-Sixty HealthSelene ParekhDigital Health Advisor at Excelerate Health VenturesJai ParekhDigital Health Advisor at Excelerate Health VenturesTom InselCo-Founder, Mindstrong, NIH at AIF
+ 3 more
